Abstract: In one embodiment, a prefabricated container is modified as a medical isolation room by replacing an original door with a clear front door. An intake louver and an adjustable damper are disposed at a lower part of the front end. An exhaust vent is disposed at an upper part of the back wall. An exhaust fan and a HEPA filter are coupled to the exhaust vent. Washable coverings cover interior sides of the container to provide washable, nonslip interior surfaces. The exhaust fan and the adjustable damper at the intake louver are controlled to produce in the medical isolation room a negative air pressure of at least about minus 0.01 inch of water gage (approximately 2.5 pascals) and a displacement ventilation exhaust flow rate through the exhaust vent of at least about 100 cubic feet per minute (cfm) greater than an intake flow rate through the intake louver.

Abstract: A clamping assembly for adjustably connecting a device to a rail, including a clamp body, rail interface mechanism, and support mechanism for the device. The rail interface mechanism attaches to rails of various heights and thicknesses with a single user control activation. The rail interface mechanism includes at least one flanged fixed upper jaw, a rail clamp control comprised of a threaded vertical axle terminating in a pin end, a flanged lower jaw constrained to slidable vertical motion along an internal face of the clamp body by the pin end of the vertical axle, and two angled wedges that can be extended and retracted horizontally.

Abstract: Provided are an obstetric and gynecologic diagnosis apparatus and an obstetric and gynecologic diagnosis method using the same. The obstetric and gynecologic diagnosis apparatus includes a chair unit on which an object is mounted, the chair unit including an upper body support, a seat, and a leg cradle sequentially arranged in one direction and connected to each other; a storage configured to store body information of the object; an input interface configured to input identification (ID) information of the object; a controller configured to generate a control signal for moving at least one of the upper body support, the seat, and the leg cradle according to first body information of the object identified by the input ID information; and a driver configured to generate a driving force for moving at least one of the upper body support, the seat, and the leg cradle according to the control signal.

Abstract: The device and methods disclosed herein allow an individual to create and sustain a differential stretch to the anterior muscles and ligaments of the torso, hips, and legs. The device includes a base frame, a vertical member secured to the base frame, a rotational lift lever secured to the vertical member at a vertical pivot member, a lower extremity elevation member secured to the rotational lift lever, and at least one lower extremity attachment device secured to the lower extremity elevation member. In methods of use, the device lifts an individual's legs off the ground, while the person is lying face down, to create a stretch in the anterior muscles, fascia, or ligaments. The device has various planes of rotation, which allows for differential stretching in the various quadrants of the person's torso. The device is height adjustable and displaceable along a track to accommodate different body types.

Abstract: An assistance apparatus includes a first wire and a second wire that couple an upper-body belt and a left knee belt to each other on or above a front part and back part of the body of a user, respectively, a third wire and a fourth wire that couple the upper-body belt and a right knee belt to each other on or above the front part and back part of the body of the user, respectively, a motor, a left sensor on the left hand of the user, and a right sensor on the right hand of the user. When a force is applied to the left sensor and no force is applied to the right sensor, the motor makes the tension of the second wire and the third wire greater than the tension of the first wire and the fourth wire. When a force is applied to the right sensor and no force is applied to the left sensor, the motor makes the tension of the first wire and the fourth wire greater than the tension of the second wire and the third wire.

Abstract: The driving system comprises: a first support structure; a second support structure supported by the first support structure for rotation about a stationary axis of rotation; a first actuation unit having a first motor device and a first output member; and a second actuation unit having a second motor device and a second output member. The first output member is drivingly connected with the second support structure for rotation about the first axis of rotation. The first motor device controls the rotation of the first output member, along with the second support structure, about the first axis of rotation. The second output member is supported by the second support structure for rotation about a second axis of rotation. The second motor device controls the rotation of the second output member about the second axis of rotation.

Abstract: A cushion for decompressing the human spinal column comprises a body support surface, a first short flat bottom surface, a longer second flat bottom surface, wherein the first bottom surface and the second bottom surface intersect and are angled at a particular angle lying within the range of 120 degrees to 150 degrees, but preferably at 135 degrees. A cushion for decompressing the human spinal column comprise a body support surface, and a curved bottom surface wherein the curve of the bottom surface increases or decreases in radius from one end to the other. The curve of the bottom surface may have the shape of an incomplete portion of a two-dimensional spiral.

Abstract: An assistance apparatus includes wires, each of which couples an upper-body belt and one of left and right knee belts to each other, and a motor.

Abstract: An assistance apparatus includes a first wire and a second wire that couple an upper-body belt and a left knee belt to each other, respectively, a third wire and a fourth wire that couple the upper-body belt and a right knee belt to each other, respectively, and a motor. When assistance is stopped, the motor is configured to reduce tension of the first wire during a first stop period starting in a boundary period in a first period and ending in a start period of a second period, generate no tension in the second wire during the second period, reduce tension of the third wire during a second stop period starting in a boundary period in a third period and ending in a start period of a fourth period, and generate no tension in the fourth wire during the fourth period.

Abstract: A walking training system includes: a treadmill on which a walking trainee walks; a walking assistance apparatus that is mounted on a leg part of the walking trainee and assists walking of the walking trainee; and control means for controlling an operation of the walking assistance apparatus. The control means controls the operation of the walking assistance apparatus so as to cause the walking trainee to approach a reference position when the trainee is spaced apart from the reference position of the treadmill by a predetermined distance or more in a walking front/back direction while the walking trainee is walking on the treadmill, and increases the predetermined distance when at least one of a walking training amount of the walking trainee, a walking training level of the walking trainee set in the walking training system, and the speed of the treadmill is larger/higher/greater than a predetermined amount, level, and speed.

Abstract: A device for the prevention of stroke is provided that has a processor, a compression system, a compression member, and a vascular probe carried by the compression member. The vascular probe senses a parameter of a circulation system from a closed neck artery that is not being externally accessed. The processor processes the closed parameter and based upon this processing communicates with the compression system to instruct the compression system to actuate the compression member. The compression member and vascular probe are external to the interior of the patient when the vascular probe senses the closed parameter of the circulation system.

Abstract: A Meibomian Gland Roller system allows for self-administered the treatment for a leading cause of dry eyes, namely, tear film oil deficiency. The system combines an effective and safe technique to combine mechanical rolling pressure with heat for meibomian gland drainage. The rolling action of the roller cylinder combined with the roller head to increase effectiveness in etnpting inspissated meibomian glands. The roller allows the patient to safely start the application of the pressure at the bottom of the glands and effectively roll open clogged oil glands. The washable roller keeps the head clean for long term use. A preheated eye-shaped soft gel pad can prepare the lids before the roller tip is applied by heating and softening the meibomian gland contents, allowing the roller to have a more effective action to induce mechanical extraction of the gland content.

Abstract: A stimulation device is provided in accordance with one embodiment. The stimulation device includes a chamber which has a flexible wall portion. A drive unit of the stimulation device is in physical communication with the flexible wall portion so as to cause deflections of the flexible wall portion in opposing directions, thereby resulting in a changing volume of the chamber. The changing volume of the chamber results in modulated positive and negative pressures with respect to a reference pressure. An opening of the stimulation device is for applying the modulated positive and negative pressures to a body part. The stimulation device includes a control device for controlling the drive unit.

Abstract: A display device includes a cover part, a driving unit for transmitting an external force to the human body through the cover part, and a display unit that is provided at a position of the cover part through which the external force is transmitted to the human body, and indicates a display in accordance with the external force transmitted from the driving unit.

Abstract: A medical device (100) comprises a container receiver unit (110) configured to receive and hold a container (120), wherein the container (120) accommodates a pharmaceutical product (125) and comprises a first communication tag (130) configured to store information regarding the pharmaceutical product (125), a reader unit (140) configured to wirelessly read the information from the first communication tag (130), and a control unit (150) configured to control the medical device (100) based on the information read from the first communication tag (130). The medical device (100) further comprises an opening or a transparent window (165) allowing to at least partially see from the outside the container (120) inserted into the container receiver unit (110), wherein the reader unit (140) comprises a first antenna unit (142, 144), and the container (120) inserted into the container receiver unit (110) is located between (i) the opening or the transparent window (165) and (ii) the first antenna unit (142, 144).

Abstract: An apparatus for holding one or more vials of a fluid that is to be protected, including an insulator housing that includes separate housing halves that, when joined together, form an internal space and a recess, a two piece carrier that is disposed within the recess formed by the separate housing halves, and a one piece vial rack supported by the two piece carrier. The one piece vial rack has a plurality of vial passages each for accommodating an elongated vial that contains a biological substance.

Abstract: Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The total quantity of doses to be contained in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, collectively referred to as prescription parameters, are determined and controlled solely by a health care provider (HCP) such as the patient's physician. In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose.

Abstract: A pacifier ball comprising a hollow sphere comprising a pair of identical hemispherical members having circular hemispherical rims separably joined together to form the hollow sphere. A first pair of hollow pliable nipples being mounted on and projecting radially outward, from one of the hemispherical members. The nipples of the first pair of hollow pliable nipples having centerlines projecting through the center of said sphere and defining therewith a first common plane. A second pair of hollow pliable nipples being mounted on and projecting radially outward from the other hemispherical member. The nipples of the second pair of hollow pliable nipples having centerlines projecting through the center of said sphere and defining therewith a second common plane.

Abstract: A pacifier device includes a body. A first arm extends from the body. A first sucker is coupled to a distal end portion of the first arm. A second arm extends from the body. A second sucker is coupled to a distal end portion of the second arm.

Abstract: The present disclosure provides an inorganic dental filler including a surface treated with at least one silane. Exemplary silanes described in the present disclosure for the surface treatment of the inorganic filler include silanes of Formula I and/or Formula II: (RSi)—(CR1R2)n—(NH—C(O)—O—CH2—CH2)q—N(R5)—C(O)—NH—(CH2—CH2—O)t—CR3R4—CH2-(A) Formula I (RSi)—(CR1R2)n—NH—C(O)—O—CR3R4-(L)q-CH2-(A) Formula II, wherein: RSi is a silane-containing group of the formula —Si(Yp)(R6)3-p, wherein Y is a hydrolysable group, R6 is a monovalent alkyl or aryl group, and p is 1, 2, or 3. Methods of making and using the surface treated inorganic dental fillers are also disclosed.

Abstract: The subject of the present application is an antiperspirant composition for personal body care having improved stability of the suspension contained, which contains a mixture of at least one oil, rice starch, at least one hydrophobically modified clay mineral and an antiperspirant active substance in the form of spherical particles.

Abstract: The present invention has as its object the provision of an aerosol composition for hair which has excellent deodorization effect and silky feeling and in which a powder hardly floats at an applied area, and an aerosol product for hair. An aerosol composition for hair of the present invention is characterized by comprising: 2 to 7% by mass of an oil absorbing powder having an oil absorption of 0.45 to 0.75 ml/g; 0.1 to 0.6% by mass of a polyol; 3 to 33% by mass of a lower alcohol; and 65 to 94% by mass of a hydrocarbon having 3 to 5 carbon atoms which has a vapor pressure of 0.05 to 0.35 MPa at a temperature of 20° C.; and containing no surfactant. An aerosol product for hair of the present invention is characterized by comprising the aerosol composition for hair filled in an aerosol container which is a pressure-resistant container having an aerosol valve, and in that the discharge amount is 0.3 to 1.2 g/second.

Abstract: A silicone emulsion free of a surfactant and an emulsifier is disclosed. The emulsion includes a dispersed oil phase having a polyorganosiloxane with one or more hydroxyl groups in a continuous aqueous or anhydrous organic diol phase including an anionic polymer.

Abstract: The present invention relates to a process for permanent shaping and dyeing carried out one after another with compositions providing improved and milder shaping and dyeing of hair, especially human hair. The inventors of the present invention have unexpectedly found out that when commonly used permanent shaping and dyeing compositions are mixed with another composition comprising predominantly carboxylic acids, the permanent shaping and dyeing effects of the compositions are improved, homogeneous permanent shaping and dyeing of hair fibers is achieved and natural cosmetic properties of hair are maintained.

Abstract: The present invention provides active compositions that contain an aluminum system active, a buffer comprising urea or an amino acid in free or salt form; and a calcium ion source. The compositions are stable at high pH; i.e., at a pH above 4 or 5, reaching neutral or basic pH.

Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.

Abstract: This invention relates to a topical, cosmetic or dermatological composition, comprising a 1,3 diglyceride having the general formula (I), in which the radicals R1 and R2 represent, independently of one another, a C13 to C40 saturated and linear alkyl radical, and at least one cosmetic or dermatological excipient for a topical application on the skin. This invention also relates to such a composition, or a 1,3 diglyceride having the formula (I), for its use in protecting the skin, in countering the weakening of the skin barrier and in preventing or reducing the penetration of exogenous molecules into the skin following a weakening of the skin barrier.

Abstract: Compositions comprising one or more chelating agents and optionally zinc ion salts are used to inhibit the growth or biofilm formation in bacteria associated with personal care products such as ophthalmic, pedicure, manicure or podiatric solutions. The compositions of the present application can also comprise gelling agents, antimicrobials, antibiotic or a pH adjuster. The compositions may be in the form of a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, soap and a cleaner.

Abstract: A method for shaping keratin fibres comprising: providing a crosslinking composition, wherein the crosslinking composition comprises: an active agent, wherein the active agent is a carbonate ester; and wherein the active agent has a molecular weight of 500 g/mol or less; a photocatalyst; a cosmetically acceptable carrier; and applying the crosslinking composition to keratin fibres, mechanically shaping the keratin fibres with an appliance at a temperature of from about 80° C. to about 180° C. and exposing the composition to electromagnetic radiation having a wavelength of from about 300 nm to about 750 nm. Also a related composition, use, kit and process.

Abstract: A malodor reducing composition is provided. The composition includes a perfume mixture including (a) at least one odor-reducing material; and (b) at least one N-heterocycle selected from an aromatic N-heterocyclic moiety and N,S-heterocyclic moiety. The at least one odor-reducing material exhibits an Odor Value (OV) having a common decimal logarithm (log10 OV) of greater than about 5.5.

Abstract: A peptide consisting of an amino acid sequence of SEQ ID NO: 1, 2, 3, or 4, a pharmaceutical composition for preventing or treating skin disease including the peptide, a cosmetic composition for skin condition improvement including the peptide, a food composition for skin condition improvement including the peptide, a method of preventing or treating skin disease using the peptide, and a use of the peptide in preventing or treating skin disease or improving skin condition are described.

Abstract: The invention provides a personal care composition comprising polymers having the structure: wherein Q, R1, a, b, and c are described herein. The invention further provides hair care compositions comprising the polymers. Particularly, the hair care composition is a hair styling composition that provides hairstyle retention at a relative humidity exceeding about 40 percent. The invention furthermore provides a method of providing hairstyle retention to hair at a relative humidity exceeding about 40 percent, the method comprising applying to hair the hair care composition as described herein.

Abstract: A rinse off hair treatment composition comprising; a. a pressure sensitive adhesive emulsion comprising one or more pressure sensitive polymer, wherein the pressure sensitive polymer is not silicone pressure sensitive polymer, and b. at least one material selected from the group consisting of i) a hair conditioning agent; ii) a hair cleansing agent, and, c. a deposition aid.

Abstract: High shine single phase color cosmetic compositions that are flexible and resistant to water below a selected temperature, 43° C. for example. The compositions wear well, are smudge and flake resistant, as well as oil resistant, making them very suitable as high shine, long wear cosmetics. Compositions according to the invention comprise specific combinations of acrylates/VA copolymer and acrylates copolymer in a cosmetically acceptable base or delivery vehicle. Compositions according to the invention are hydrophilic and easily removed when scrubbed with water above a certain temperature, but not as easily removed with water below that temperature. The compositions are easy to manufacture, flexible and comfortable, and suitable for use on skin, hair and nails, particularly as eye shadow, eyeliner, lip products, tattoo products and mascara. Compositions may be formulated as liquid eyeliner, liquid eye shadow, mascara, liquid lip products and tattoo products.

Abstract: A cosmetic composition for temporarily reshaping keratin fibres, said composition containing: a) at least one non-cross-linked, hydrophobically modified (meth)acrylic acid copolymer b) at least one vinyl caprolactam copolymer, use thereof, and method utilising a composition of this kind.

Abstract: The present disclosure related to an oral composition, and more particularly, to an oral composition for reducing tooth sensitivity. More specifically, the oral composition contains zinc and a copper salt capable of occluding dental tubules by agglomerating proteins, contributing to the reduction effect of tooth sensitivity, and to maintain this, allows a water soluble or alcohol soluble polymer to coat the dental tubules and be maintained for a long time, thereby solving the main cause of tooth sensitivity, as a result, providing an effect on the prevention or reduction of symptoms of tooth sensitivity in a short time.

Abstract: A cream to be applied topically to the hair and scalp in order to infuse moisture. The present invention effectuates this capability through a mixture of a raw material blend, in a chemical composition’ proportion that brings about effective results. The prevailing ingredients in the finished product are pumpkin seed oil (Cucurbita pepo), rosehip seed oil (Rosa canina L.), mango butter (Mangifera indica), and citric acid.

Abstract: Disclosed are methods of treating aging effects on a subject skin, comprising contacting the skin with a skin microbiome complex, including topical compositions containing YM Microbiome Complex and Advanced Probiotic Complex, methods of treatment using the compositions and methods of preparing the compositions for preventing, slowing, and reversing skin aging. Also disclosed are related formulations and methods of skin microbiome transplantation.

Abstract: A composition of matter for dental plaque removal comprising at least one of a strain of the bacteria Bacillus licheniformis and the extracellular enzymes produced by B. licheniformis, and at least one of a natural and synthetic polymer, are disclosed. A method of manufacturing an animal chew or food item coated with the disclosed composition of matter, and animal chews or food items produced therefrom, are also disclosed.

Abstract: Disclosed is a method of exfoliating skin. The method can include topically applying an effective amount of a composition to skin in need thereof. The composition can include an alpha hydroxy acid, 4-tert-butylcyclohexanol, an aqueous extract of plankton comprising an exopolysacchride synthesized by Vibo alginolyticus, an aqueous extract of Phragmites communis, an aqueous extract of Poria cocos, and an aqueous extract of Cucurbita pepo (pumpkin) seed.

Abstract: An ophthalmic drug delivery device and a method for fabricating the same are provided. The ophthalmic drug delivery device includes a shield element and a drug release element. The shield element has a light transmittance more than or equal to 80%. The drug release element is an annular body so that the drug release element surrounds the shield element. The drug release element is neutral and includes a cross-linked neutral collagen, a first hydrophilic biodegradable polymer and a drug. The shield element is acidic and includes a cross-linked acidic collagen and a second hydrophilic biodegradable polymer.

Abstract: Provided herein is a storage stable non-fluoride toothpaste composition enriched with a dietary supplement containing both oil soluble and water soluble vitamins. The dietary supplement is incorporated into the toothpaste, the dietary supplement containing a water soluble vitamin portion including at least one water soluble vitamin and an oil soluble vitamin portion. The oil soluble vitamin portion includes at least one oil soluble vitamin, a carrier oil and an emulsifier. The toothpaste is thereby formulated in a manner such that oral application will result in systemic delivery of at least a portion of the dietary supplement to meet a 2% RDI threshold even when 3 or less serving sizes are orally applied.

Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.

Abstract: The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.

Abstract: A polyfunctional radical scavenger hydrogel formulation providing extended protection of the extracellular space within a wound site. The polyfunctional radical scavenger hydrogel formulation is generally formed from a hydrogel, a first radical scavenger and a second radical scavenger differing from the first radical scavenger with respect to at least one property. A portion of the first radical scavenger included with the formation and/or second radical scavenger included within the formulation may be dissolved, suspended and/or bonded to a polymer of the hydrogel.

Abstract: The present invention provides a method of treatment of inflammatory disorder of the eye, said method comprising administering into the eye of a person in need thereof, an aqueous solution comprising difluprednate as the sole active ingredient at a concentration of 0.02% to 0.04% weight by volume in an aqueous vehicle, wherein the solution is free of oil and wherein the solution is administered twice-a-day. The present invention also provides an ophthalmic solution comprising a. therapeutically effective concentration of difluprednate, a crystal growth inhibitor and pharmaceutically acceptable amounts of a solubilizer comprising a mixture of i. quaternary ammonium compound and ii. polyethoxylated castor oil, b. in an aqueous vehicle. wherein the crystal growth inhibitor is polyvinyl alcohol or its derivatives.

Abstract: Disclosed herein is an analgesic solution for the treatment of pain comprising a pain-relieving effective amount of tramadol or a pharmaceutically acceptable salt thereof, a method of treating pain by administering said analgesic solution to a subject in need thereof, a kit that includes containers of the analgesic solution, and a dosing regimen for the analgesic solution.

Abstract: The present invention relates to a rhinovaccination system of influenza vaccine, comprising a medical syringe filled with an influenza vaccine composition which comprises an inactivated whole influenza virion and a gel base material comprising carboxy vinyl polymer to administer the influenza vaccine composition to nasal mucosa, which is characterized by not comprising an adjuvant.

Abstract: Unique foamable vehicles or carriers comprising at least one wax, waxy substance, counterpart or derivative, a stabilizer, water, and a propellant are provided. In some embodiments, the wax is a liquid wax. In some embodiments, the wax includes a solid wax and a liquid wax. The compositions are substantially free of crystals. The components are selected to provide a composition that is substantially resistant to aging and to phase separation, and/or can substantially solubilize and or stabilize active ingredients. Pharmaceutical and cosmetic compositions with potentially enhanced skin delivery and their uses are also provided.

Abstract: Provided herein are liposomal compositions for improved delivery and penetration into the skin. Liposomal compositions as provided herein comprise one more peptides. Also provided herein are compositions and methods for targeting dermal white adipose tissue to improve fat reduction and anti-aging effects. Compositions and methods for targeting dermal white adipose tissue may comprise administering a composition comprising liposomes.